Abstract Using the techniques of computer-aided drug design, the docking of Survivin and known active small molecules was simulated and then the key amino acid residue fragment of the target protein was analyzed. It led to the discovery of active groups capable of binding to the critical sites. Through the use of the natural product, Oleanolic Acid, as a lead compound, the introduction of the active groups onto the Aring, and the modification of the carboxyl group at the C-28 position using esterification or amidation, twenty new Oleanolic acid derivatives had been designed and synthesized.A549 and SGC-7901 cells were used to screen the antitumor activity in vitro through the standard MTT method. The compounds, II 3 , III 5 and Ⅳ 4, exhibited more potent cytotoxicity than positive drugs.
Introduction
Oleanolic acid (OA) is a pentacyclic triterpenoid compound widely presenting in plants in the form of dissociation or in the combination with sugars [1] . Its effective ingredients were mainly extracted from Prunella vulgaris, Honeysuckle, Olive, Forsythia, Aloe Vera and Ligustrum lucidum and other plants [2] . Oleanolic acid has a multitude of important pharmacological functions, such as anti-virus [3] [4] [5] , anti-diabetic and hypoglycemic, anti-HBV, and anti-tumor. Our research group has carried out a research on the anti-tumor activity of the pentacyclic triterpenoid analogues since 2000, with main focus on the extensive structural modification of inactylactic acid, ursolic acid, asiatic acid, and on the evaluation of vitro antitumor activity [6] [7] [8] [9] . In addition, some progress has been made in guiding the structural transformation of oleanolic acid, ursolic acid and asiatic acid, using computer-aided design to simulate the combination of analogue analyte with protein target [10] [11] . Survivin, a member of the family of apoptotic proteins, plays a key role in cell division and inhibition of apoptosis and is considered an important target for anticancer therapy [12] .Survivin protein can inhibit the apoptosis and regulate the mitotic function of cells by inhibiting various endogenous and exogenous apoptosis-related factors such as Caspase3, Caspase7 and P53. Survivin is overexpressed in a variety of tumor tissues and hardly expressed in the normal cells. It is also closely related to poor prognosis and drug resistance. However,Inhibiting Survivin as a new strategy for the treatment of cancer and to overcome the drug resistance of tumor cells [13] . Oleanolic acid (OA) and 5-fluorouracil(5-FU) in combination inhibit Survivin which led to the significant increase in human pancreatic cell (Panc-28) apoptosis [14] . OA can improve the proapoptotic protein Bax, change the balance of Bcl-2/Bax, and significantly reduce the expression of anti-tumor apoptotic protein, Survivin [15] .YM155 has a naphthoquinolidazole structure that inhibits the transformation of Survivin gene through inhibiting the promoter activity [16] [17] , Their research level nearly reaches the clinical stage I, II study.SC144, with the structure of a quinolide hydrazine, can inhibit the IL-6/gp130/Stat3 signal axis, bind gp130, induce gp130 phosphorylation and deglycosylation, prevent Stat3 phosphorylation and nuclear migration, and ultimately inhibit the downstream expression of Survivin [18] . It is the first oral active inhibitor of gp130.By combining the three-dimensional crystal structure (PDB: 3UIH) of Survivin protein in the PDB database, analyzing the interaction between known Survivin small molecule inhibitor and target enzyme using molecular simulation docking method, and analyzing the key amino acid residue fragment, we were able to determine the active groups that can bind to the critical site ( Figure 1 ). We further introduced the active group fragments in the partial inhibitor structure were introduced into the tricyclic triterpenoid matrix. The main transformation was concentrated in the parallel nitrogencontaining heterocyclic ring of the A-ring ( Figure 2 ). As a result, twenty new oleanolic acid analogs were designed, synthesized and tested for in vitro activity. In this essay, we combined the structural modification of pentacyclic triterpene compounds suggested by Meng's research team with the antitumor compounds which have entered the clinical study ( Figure 1) and the computer simulation to analyze the structure of the key active groups (Figure 2 ). We introduced these groups to A ring of oleanolic acid. In the computer simulation of molecular docking, the combination mode of II 3 、Ⅲ 5 and Ⅳ 4 with Survivin targeting protein has displayed a strong combining ability. The antitumor activities have been tested in vitro by MTT method. The results showed that compounds Ⅲ 5 and Ⅳ 4 have more outstanding antitumor activities on A549 and SGC-7901 cells than gefitinib.
Results and discussion

Chemical Synthesis
A total of 20 compounds were designed and synthesized from four categories with OA as original material. The target compound route was shown in Scheme 1. First, the Jones reagent was used to oxidize the oleanolic acid at the 3-position hydroxyl group to the ketone to obtain OA-1. On this basis, the 28-carboxyl group was esterified or amidized to obtain the compound OA-2 and OA-6. Then they reacted with (T-BuOK) respectively, resulting in compounds OA-3 and OA-7 under basic conditions at 50℃, which are further synthesized to result in olean-2-ene- [2,3-b] pyrazin-12-ene-28-carboxylic acid ester compounds I 1 -I 4 , 5'-methyl-olean-2-ene- [2,3-b] pyrazine-12-ene-28-oic acid ester compounds II 1 -II 5, and 5'-methyl-olean-2-ene- [2,3-b] pyrazine-12-ene-28-carboxylic acid amide compounds Ⅳ 1 -Ⅳ 5 . In addition, OA-2 reacted with hydrazine hydrate to gain OA-5, which, after cyclization, forms olean-2-ene- [2,3-b] imidazole-12-ene-28-oic acid ester Ⅲ 1 -Ⅲ 5 .
Scheme1 Synthetic routes of target compounds.
Biological evaluation
The inhibitory activity of target compounds I-Ⅳ on A549 and SGC-7901 cells was tested in vitro by the MTT method, meanwhile gefitinib and Adriamycin acted as the positive control. As shown in Table 1 , all the tested compounds indicated some inhibitory effect on A549 and SGC-7901 cells. Among the compounds, II 3 , III 5 and Ⅳ 4 showed excellent inhibitory effects on A549 cells (IC50 =8.31µM, IC50 =7.82µM, IC50 =5.31µM) and SGC-7901 cells (IC50=6.22µM,IC50 =4.27µM,IC50 =7.92µM). (-75.542 ).The lower the energy score is, the stronger the binding affinity becomes. Through intuiting analysis of the combination of compounds and targets by the Discovery Studio 4.0, we found that some compounds interacted with Survivin protein and closely connected with the surrounding amino acids. Based on Figure 3 -5, compounds II 3 , III 5 and Ⅳ 4 were firmly fixed in the hydrophobic pocket and they interacted with key amino acids through hydrophobic bond and H-bond. Key energy could not be measured in the process of the molecular docking. MolDock score of all compounds are shown in Table 2 . In this step, we cooperated with Shenyang Pharmaceutical University. 
Conclusions
In summary, four new series of OA derivatives were designed and synthesized. Their antitumor activities on A549 and SGC-7901 cell lines were evaluated. All the tested compounds showed some anticancer activity against A549 and SGC-7901 cell lines. Molecular docking studies demonstrated that twenty OA derivatives were obtained through structural optimization of the lead compound(OA) and they docked into Survivin protein-tyrosine kinase. Molegro Virtual Docker (MVD) was able to tell if there was good binding affinity of the synthesized all compounds with Survivin protein. Specifically, compounds II 3 、III 5 and Ⅳ 4 exhibited outstanding inhibitory activities on A549 cells (IC50 =8.31µM, IC50 =7.82µM, IC50 =5.31µM) and SGC-7901 cells (IC50=6.22µM,IC50 =4.27µM,IC50 =7.92µM). As the ester chain of OA increases, the anticancer activity increases. The structure-activity relationships of newly synthesized compounds have shown in Figure 6 . Our data indicated that proper structural modification at A ring and C-28 position of OA was necessary to enhance the anticancer activity of Oleanolic acid. 
Experimental
General experimental procedures
The melting points were determined on a Büchi B-540 melting point apparatus produced by Broker Corporation (Flawil, Switzerland) and are uncorrected.
1 HNMR spectra were recorded on Bruker a ARX-300 MHz spectrometers from Bruker Corporation (Ettlingen, Germany) and the solvent is CDCl3, using trimethylsilane as an internal standard. ESI-MS were measured on a Thermo-Finnigan LCQ equipment from Thermo Finnigan (San Francisco, CA, USA). Thin-layer chromatography (TLC) ware carried out with GF 254, column chromatograph with silica gel (200-300 mesh) obtained from Qing-dao Marine Chemical Factory (Qingdao, China). The reagents were all of analytical grade or chemically pure.
Preparation of the compounds 4.2.1. 3-Oxo-olean-12-ene-28-oic acid (OA-1)
OA (0.500g) was dissolved in 50 mL of acetone,and allowed to react with the newly prepared Jones' reagent (0.64mL) under ice bath. The end of the reaction was detected by TLC. 15 mL of isopropanol was added to quench its oxidizing property and stirred at room temperature for 30 min. A small amount of saturated sodium chloride solution and moderate ethyl acetate were added to the reaction mixture to extract for three times. The organic layer was dried with anhydrous magnesium sulfate for 4 h .The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate =12/1(V/V)).Then, the solvent were removed to give a powder OA-1, with a yield of 98.0%. m.p. 200.4~202.1 o C.
3-Oxo-olean-12-ene-28-oic acid ethyl ester (OA-2)
To a solution of OA-1(0.500g) in N,N-dimethylformamide (DMF), were added anhydrous K2CO3 (30mg, 0.22 mmol) and bromoethane (0.24mL,5.02mmol) at room temperature for 5h. The end of the reaction was detected by TLC. (developing solvent: petroleum ether/ethyl acetate=5/1(V/V)). The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate =15/1(V/V)) to give 0.324 g of white flaky solid OA-2, 57.9%. m.p.189.4~191.1 o C.
2,3-Dioxo-olean-12-ene-28-oic acid ethyl ester (OA-3)
The intermediate OA-2 (0.300g) was dissolved in 10mL tert-butanol(t-BuOH) solution and reacted at 50 o C. After completely dissolving, 0.15 g of potassium tertbutoxide was added and 1.5 mL of tetrahy-drofuran was added as catalyst. The end of the reaction was detected by TLC.(developing solvent: petroleum ether/ethyl acetate=5/1(V/V)),6h reaction end. The organic layer was dried with anhydrous magnesium sulfate for 4 h.The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate =15/1(V/V)) to give 0.245 g of white flaky solid OA-3 in yield 80.24%. m.p.187.7~187.2 o C.
5', 6'-dihydro-olean-2-ene-[2,3-b]pyrazin-12-ene-28-oic acid ethyl ester (OA-4)
OA-3 (0.300 g) was dissolved in 10 mL of absolute ethanol and 0.5 g of anhydrous magnesium sulfate was added.The supersaturated ethylenediamine-ethanol solution (0.04 mL ethylenediamine) was slowly added into the system, and the mixture was 
2-hydrazone-3-Oxo-olean-12-ene-28-oic acid ethyl ester (OA-5).
OA-2 (0.300 g, 0.62 mmol) was dissolved in 30 mL of methanol. 1 mL of hydrazine hydrate was added and heated to reflux. The end of the reaction was detected by TLC.(developing solvent: petroleum ether/ethyl acetate=3/1(V/V)), 2h reaction ends. The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate =15/1(V/V)) to give 0.226 g of a yellow oil, OA-5, in a yield of 72.30% . m.p.201.1~203.7 o C.
2-Oxo-olean-12-ene-28-acyl-aniline (OA-6)
25mL of dry dichloromethane(DCM )and oxalyl chloride (1.20mmol) were added into the intermediate OA-1 (0.500g) for 4h. The reaction solvent and unreacted oxalyl chloride were removed by steaming, and the residue was added with 10 mL of cyclohexane, followed by distillation of cyclohexane under reduced pressure for three times. Acid chloride was added 15mL DCM, and triethylamine adjusted to pH 9 ~ 10,adding aniline (2.2mmol), room temperature reaction 6h, TLC detection reaction endpoint.The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate = 20/1(V/V)) to give the desired product. 0.396 g of pale yellow crystals of OA-6, in a yield of 77.36%. m.p.122.4~124.7 o C.
2,3-Dioxo-olean-12-ene-28-acyl-aniline(OA-7)
The intermediate OA-6(0.300g) was dissolved in 10mL tert-butanol(t-BuOH) solution and reacted at 50 
Olean-2-ene-[2,3-b] pyrazin-12-ene-28-oic acid npropyl ester (I 2 )
According to the same method for compound I1, compound I2 was prepared from OA-1 (1.1mmol) and brominated npropane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0. 32(s,3H),1.25(s,3H),1.13(s,3H),1.12(s,3H),1.02(s,3H) 
Olean-2-ene-[2,3-b] pyrazin-12-ene-28-oic acid nbutyl ester (I 3 )
According to the same method for compound I1, compound I3 was prepared from OA-1 (1.1mmol) and brominated nbutylane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.362 g of a white powder as a solid in 73.5% yield. 
Olean-2-ene-[2,3-b] pyrazin-12-ene-28-oic acid npentyl ester(I 4 )
According to the same method for compound I1, compound I3 was prepared from OA-1 (1.1mmol) and brominated npentane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.343g of a white powder as a solid in 68.3% yield. m.p. 163 
Olean-2-ene-[2,3-b] pyrazin-12-ene-28-oic acid nhextyl ester (I 5 )
Using the same method for preparing compound I1, compound I3 was made from OA-1 (1.1mmol) and brominated nhexane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.384g of a white powder as a solid in 76.3% yield. m. 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-oic acid ethyl ester (Ⅱ 1 )
The intermediate OA-3(0.500g) was dissolved in 20 mL of absolute ethanol and 0.5 g of anhydrous magnesium sulfate was added. Then the supersaturated 1,2-propanediamine-ethanol solution (0.04 mL) was slowly added into the system, being stirred at 79 o C for 8 h. The solvent was removed by evaporation under the condition of reduced pressure. The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate =15/1(V/V)) to give 0. 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-oic acid npropyl ester(Ⅱ 2 )
According to the same method for compound II1, compound II2 was prepared from OA-1 (1.1mmol) and brominated npropane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.283g of a white powder as a solid in 40.31% yield. m.p.168.8~171. 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-oic acid nbutyl ester (Ⅱ 3 )
According to the same method for compound II1, compound II3 was prepared from OA-1 (1.1mmol) and brominated nbutylane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.303g of a white powder as a solid in 60.24% yield. m.p. 164 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-oic acid npentyl ester (Ⅱ 4 )
According to the same method for compound II1, compound II4 was prepared from OA-1 (1.1mmol) and brominated npentane (4.4 mmol), The crude product was purified using silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.322g of a white powder as a solid in 64.51% yield. 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-oic acid nhextyl ester (Ⅱ 5 )
According to the same method for compound II1, compound II4 was prepared from OA-1 (1.1mmol) and brominated nhexane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent:petroleum ether/ethyl acetate=20/1(V/V)) to give 0.304g of a white powder as a solid in 63.29% yield. m.p.196.2~199. 
olean-2-ene-[2,3-b] imidazole-12-ene-28-oic acid ethyl ester (Ⅲ 1 )
A solution of intermediate OA-5 (1.10 mmol) was dissolved in 20 mL of absolute ethanol, and formic acid (1.10 mmol) was added and heated to reflux.3h latter,.Then the product was poured into cold water and filtered. After drying, the crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1(V/V) ) to give 0.204 g of white crystals III1 in 43.29% yield mp 196.2~199. 
olean-2-ene-[2,3-b] imidazole-12-ene-28-oic acid npropyl ester(Ⅲ 2 )
According to the same method for compound Ⅲ1, compound Ⅲ2 was prepared from OA-1 (1.1mmol) and brominated npropane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.192g of a white powder as a solid in 40.15% yield. m.p.188.8~192. 
olean-2-ene-[2,3-b] imidazole-12-ene-28-oic acid nbutyl ester (Ⅲ 3 )
According to the same method for compound Ⅲ1, compound Ⅲ3 was prepared from OA-1 (1.1mmol) and brominated nbutylane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.231g of a white powder as a 
olean-2-ene-[2,3-b] imidazole-12-ene-28-oic acid npentyl ester(Ⅲ 4 )
According to the same method for compound Ⅲ1, compound Ⅲ3 was prepared from OA-1 (1.1mmol) and brominated nbutylane (4.4 mmol), The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=20/1 (V/V)) to give 0.153g of a white powder as a solid in 37.23% yield. m.p.182.3~185. 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-acylanilide (Ⅳ 1 )
The intermediate OA-7(0.500g) was dissolved in 20 mL of absolute ethanol and 0.5 g of anhydrous magnesium sulfate was added and the supersaturated 1,2-propanediamine-ethanol solution (0.04 mL) was slowly added to the system, the mixture was stirred at 79 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-acylfluaniline(Ⅳ 3 )
According to the same method for compound Ⅳ1, compound Ⅳ4 was prepared from OA-1 (1.1mmol) and m-fluoroaniline(2.2 mmol), The crude product was purified by silica gel column chromatography (eluent:petroleum ether/ethyl acetate=13/1 (V/V)) to give 0.235g of a white powder as a solid in 58.32% yield. 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-acofluoroaniline(Ⅳ 4 )
According to the same method for compound Ⅳ1, compound Ⅳ4 was prepared from OA-1 (1.1mmol) and m-fluoroaniline(2.2 mmol), The crude product was purified by silica gel column chromatography (eluent:petroleum ether/ethyl acetate=15/1 (V/V)) to give 0.523g of a white powder as a solid in 62.54% yield. m.p.208.9~211. 
5'-methyl-olean-2-ene-[2,3-b] pyrazine-12-ene-28-morphomorpholine (Ⅳ 5 )
According to the same method for compound Ⅳ1, compound Ⅳ4 was prepared from OA-1 (1.1mmol) and methoxy aniline (2.2 mmol), The crude product was purified by silica gel column chromatography (eluent:petroleum ether/ethyl acetate=15/1 (V/V)) to give 0.402g of a white powder as a solid in 55.34% yield. m.p.221.6~225. 
